Participant enrolment was lower than expected

The purpose of the protocol is to evaluate injection intervals and treatment modalities up to 3 years follow-up of botulinum toxin A (BoNT-A) in adult patients suffering from upper limb spasticity after stroke.

Inclusion Criteria:

• Subject able to comply with the protocol
• Provision of written informed consent prior to collecting the data
• Male or female patients of 18 years or older
• Presenting with upper limb spasticity after stroke for which treatment with botulinum toxin A is indicated

Exclusion Criteria:

• The subject has already been included in this survey
• Patients who already received BoNT-A treatment for upper limb spasticity
• Patients with known intolerance for BoNT-A
• Subjects unable to comply with the protocol

Patients with a history of stroke, suffering from upper limb spasticity